Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

1.

Expression of cancer/testis antigens is correlated with improved survival in glioblastoma.

Freitas M, Malheiros S, Stávale JN, Biassi TP, Zamunér FT, de Souza Begnami M, Soares FA, Vettore AL.

Oncotarget. 2013 Apr;4(4):636-46.

PMID:
23592437
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.

Reddy SP, Britto R, Vinnakota K, Aparna H, Sreepathi HK, Thota B, Kumari A, Shilpa BM, Vrinda M, Umesh S, Samuel C, Shetty M, Tandon A, Pandey P, Hegde S, Hegde AS, Balasubramaniam A, Chandramouli BA, Santosh V, Kondaiah P, Somasundaram K, Rao MR.

Clin Cancer Res. 2008 May 15;14(10):2978-87. doi: 10.1158/1078-0432.CCR-07-4821.

PMID:
18483363
[PubMed - indexed for MEDLINE]
Free Article
3.

Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications.

Balafoutas D, zur Hausen A, Mayer S, Hirschfeld M, Jaeger M, Denschlag D, Gitsch G, Jungbluth A, Stickeler E.

BMC Cancer. 2013 Jun 3;13:271. doi: 10.1186/1471-2407-13-271.

PMID:
23731661
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Overexpression of SLC7A7 predicts poor progression-free and overall survival in patients with glioblastoma.

Fan S, Meng D, Xu T, Chen Y, Wang J, Li X, Chen H, Lu D, Chen J, Lan Q.

Med Oncol. 2013 Mar;30(1):384. doi: 10.1007/s12032-012-0384-8. Epub 2013 Feb 14.

PMID:
23408368
[PubMed - indexed for MEDLINE]
5.

MRP3: a molecular target for human glioblastoma multiforme immunotherapy.

Kuan CT, Wakiya K, Herndon JE 2nd, Lipp ES, Pegram CN, Riggins GJ, Rasheed A, Szafranski SE, McLendon RE, Wikstrand CJ, Bigner DD.

BMC Cancer. 2010 Sep 1;10:468. doi: 10.1186/1471-2407-10-468.

PMID:
20809959
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy.

Saikali S, Avril T, Collet B, Hamlat A, Bansard JY, Drenou B, Guegan Y, Quillien V.

J Neurooncol. 2007 Jan;81(2):139-48. Epub 2006 Sep 27.

PMID:
17004103
[PubMed - indexed for MEDLINE]
7.

TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme.

Kuijlen JM, Mooij JJ, Platteel I, Hoving EW, van der Graaf WT, Span MM, Hollema H, den Dunnen WF.

J Neurooncol. 2006 Jun;78(2):161-71. Epub 2006 Mar 17.

PMID:
16544055
[PubMed - indexed for MEDLINE]
8.
9.

MiR-106a is an independent prognostic marker in patients with glioblastoma.

Zhao S, Yang G, Mu Y, Han D, Shi C, Chen X, Deng Y, Zhang D, Wang L, Liu Y, Hou X, Wang C, Wu J, Liu H, Wang L, Zhang G, Qi J, Fang X, Shi C, Ai J.

Neuro Oncol. 2013 Jun;15(6):707-17. doi: 10.1093/neuonc/not001. Epub 2013 Feb 14.

PMID:
23416698
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

PBEF1/NAmPRTase/Visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value.

Reddy PS, Umesh S, Thota B, Tandon A, Pandey P, Hegde AS, Balasubramaniam A, Chandramouli BA, Santosh V, Rao MR, Kondaiah P, Somasundaram K.

Cancer Biol Ther. 2008 May;7(5):663-8.

PMID:
18728403
[PubMed - indexed for MEDLINE]
Free Article
11.

SAMSN1 is highly expressed and associated with a poor survival in glioblastoma multiforme.

Yan Y, Zhang L, Xu T, Zhou J, Qin R, Chen C, Zou Y, Fu D, Hu G, Chen J, Lu Y.

PLoS One. 2013 Nov 22;8(11):e81905. doi: 10.1371/journal.pone.0081905. eCollection 2013.

PMID:
24278465
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature.

Al-Mayhani MT, Grenfell R, Narita M, Piccirillo S, Kenney-Herbert E, Fawcett JW, Collins VP, Ichimura K, Watts C.

Neuro Oncol. 2011 Aug;13(8):830-45. doi: 10.1093/neuonc/nor088.

PMID:
21798846
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Increased expression of thymidylate synthetase (TS), ubiquitin specific protease 10 (USP10) and survivin is associated with poor survival in glioblastoma multiforme (GBM).

Grunda JM, Nabors LB, Palmer CA, Chhieng DC, Steg A, Mikkelsen T, Diasio RB, Zhang K, Allison D, Grizzle WE, Wang W, Gillespie GY, Johnson MR.

J Neurooncol. 2006 Dec;80(3):261-74. Epub 2006 Jun 14.

PMID:
16773218
[PubMed - indexed for MEDLINE]
14.

Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme.

Hutterer M, Knyazev P, Abate A, Reschke M, Maier H, Stefanova N, Knyazeva T, Barbieri V, Reindl M, Muigg A, Kostron H, Stockhammer G, Ullrich A.

Clin Cancer Res. 2008 Jan 1;14(1):130-8. doi: 10.1158/1078-0432.CCR-07-0862.

PMID:
18172262
[PubMed - indexed for MEDLINE]
Free Article
15.

A multigene predictor of outcome in glioblastoma.

Colman H, Zhang L, Sulman EP, McDonald JM, Shooshtari NL, Rivera A, Popoff S, Nutt CL, Louis DN, Cairncross JG, Gilbert MR, Phillips HS, Mehta MP, Chakravarti A, Pelloski CE, Bhat K, Feuerstein BG, Jenkins RB, Aldape K.

Neuro Oncol. 2010 Jan;12(1):49-57. doi: 10.1093/neuonc/nop007. Epub 2009 Oct 20.

PMID:
20150367
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma.

Phuphanich S, Wheeler CJ, Rudnick JD, Mazer M, Wang H, Nuño MA, Richardson JE, Fan X, Ji J, Chu RM, Bender JG, Hawkins ES, Patil CG, Black KL, Yu JS.

Cancer Immunol Immunother. 2013 Jan;62(1):125-35. doi: 10.1007/s00262-012-1319-0. Epub 2012 Jul 31.

PMID:
22847020
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

ID1 affects the efficacy of radiotherapy in glioblastoma through inhibition of DNA repair pathways.

Guo Q, Guo P, Mao Q, Lan J, Lin Y, Jiang J, Qiu Y.

Med Oncol. 2013 Mar;30(1):325. doi: 10.1007/s12032-012-0325-6. Epub 2013 Feb 3.

PMID:
23377983
[PubMed - indexed for MEDLINE]
18.

Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas.

Garcia JL, Perez-Caro M, Gomez-Moreta JA, Gonzalez F, Ortiz J, Blanco O, Sancho M, Hernandez-Rivas JM, Gonzalez-Sarmiento R, Sanchez-Martin M.

BMC Cancer. 2010 Aug 24;10:454. doi: 10.1186/1471-2407-10-454.

PMID:
20735813
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy.

Zhang JG, Kruse CA, Driggers L, Hoa N, Wisoff J, Allen JC, Zagzag D, Newcomb EW, Jadus MR.

J Neurooncol. 2008 May;88(1):65-76. doi: 10.1007/s11060-008-9534-4. Epub 2008 Feb 8.

PMID:
18259692
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis.

Sreekanthreddy P, Srinivasan H, Kumar DM, Nijaguna MB, Sridevi S, Vrinda M, Arivazhagan A, Balasubramaniam A, Hegde AS, Chandramouli BA, Santosh V, Rao MR, Kondaiah P, Somasundaram K.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1409-22. doi: 10.1158/1055-9965.EPI-09-1077.

PMID:
20530493
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk